Merck acquires AmpTec to expand mRNA capabilities for vaccines, treatments and diagnostics
Diagnostics business focused on producing customized long RNAs and DNAs for in vitro diagnostics, complements existing Merck portfolio
Diagnostics business focused on producing customized long RNAs and DNAs for in vitro diagnostics, complements existing Merck portfolio
Initial findings showed that tocilizumab, a drug used to treat arthritis, was likely to improve outcomes among critically ill COVID-19 patients
The bacteria scrub out nitrogen, potentially defending against certain nutrient overloads
A research team has used genetic modification (GM) to create a new tomato variety that contains high levels of natural L-DOPA
The disease has re-emerged in major wheat growing areas and an epidemic could cause a major threat to global food security
The acquisition will offer greater flow cytometry and imaging multiplexing capabilities to meet needs in protein and cell analysis research
Working with the UK government, first vaccinations are to begin early in the new year
The real-time RT-PCR assay can simultaneously detect and differentiate 8 target genes, the first and only test to do so in the world